Author: Bhattacharjee, Chayan; Singh, Maitri; Das, Debisukti; Chaudhuri, Sujit; Mukhopadhyay, Aparna
Title: Current therapeutics against HCV Cord-id: 2qju8482 Document date: 2021_7_15
ID: 2qju8482
Snippet: Hepatitis C is a positive stranded enveloped RNA virus belonging to the Flaviviridae family. HCV infection leads to severe liver diseases, cirrhosis and hepatocellular carcinoma worldwide. Although treatments have been available for a while, due to its complexity and genetic diversity, only few are reported to be effective against all HCV genotypes. Here, we review the HCV life cycle and its immunogenic potential and various mechanisms via which the virus interferes in the signalling process. A
Document: Hepatitis C is a positive stranded enveloped RNA virus belonging to the Flaviviridae family. HCV infection leads to severe liver diseases, cirrhosis and hepatocellular carcinoma worldwide. Although treatments have been available for a while, due to its complexity and genetic diversity, only few are reported to be effective against all HCV genotypes. Here, we review the HCV life cycle and its immunogenic potential and various mechanisms via which the virus interferes in the signalling process. A comprehensive overview of current anti-HCV therapeutics, such as, Direct Acting Antiviral (DAA) as well as Host Targeting Agents (HTA), along with their scope, known mechanism of action and limitations are presented. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13337-021-00697-0.
Search related documents:
Co phrase search for related documents- act antiviral and activity broad spectrum: 1, 2
- act antiviral and adaptive immune response: 1
- action exact mechanism and low density: 1
Co phrase search for related documents, hyperlinks ordered by date